Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | +18.06% | +19.61% | -54.89% |
15/05 | 180 Life Sciences Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
09/05 | 180 Life Sciences Corp. Announces Management Changes | CI |
Chart calendar 180 Life Sciences Corp.
Upcoming events on 180 Life Sciences Corp.
No events available
Past events on 180 Life Sciences Corp.
16/02/2024 | Extraordinary Shareholders Meeting |
09/07/2023 | Gordon Research Conference |
06/07/2023 09:30 am | Annual General Meeting |
15/12/2022 | Extraordinary Shareholders Meeting |
30/11/2022 | A.G.P.’s Virtual Biotech Conference |
14/06/2022 09:30 pm | Annual General Meeting |
10/01/2022 | Biotech Virtual Conference |
10/12/2021 11:30 pm | Annual General Meeting |
02/12/2021 01:30 am | International Dupuytren Symposium |
09/09/2021 01:30 pm | British Society for Surgery of the Hand Meeting |
10/08/2021 10:30 pm | BTIG Virtual Biotechnology Conference |
10/06/2021 11:00 pm | LD Micro Invitational Investor Conference |
17/03/2021 06:30 pm | Maxim Emerging Growth Conference |
11/01/2021 04:30 pm | H.C. Wainwright Bioconnect Conference |
16/12/2020 12:10 am | LD Micro Main Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | -15,6 -15,6 -0.57% | -17,9 -16,5 -8.42% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,9 | -20,3 -25,8 20.98% | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | -10,9 | -20,3 -25,8 21.09% | -38,7 -2,37 -1533.33% |
EPS USD | Released Forecast Spread | 0,00 | -247 -308 19.75% | -387 -22,8 -1598.33% |
Announcement Date | 09/07/21 | 31/03/22 | 31/03/23 |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | -3,68 -4,34 15.22% | -4,52 -4,53 0.2% | -4,06 -4,41 8.13% |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1,56 -4,35 135.97% | 2,94 -4,54 164.8% | -21,5 0,44 -5039.54% |
Net income Million USD | Released Forecast Spread | 1,56 -4,35 135.97% | 2,94 -4,54 164.8% | -21,5 0,44 -5039.54% |
EPS USD | Released Forecast Spread | 19,0 -49,4 138.46% | 34,2 -49,4 169.23% | -209 3,80 -5600% |
Announcement Date | 16/05/22 | 09/08/22 | 10/11/22 |
Past sector events for 180 Life Sciences Corp.
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KBLM Stock
- Calendar 180 Life Sciences Corp.